Photodynamic therapy and detection of high-grade gliomas

Journal of Environmental Pathology, Toxicology and Oncology

Volumn 25, Issue 1-2, 2006, Pages 453-465

  Madsen, Steen ^a   Hirschberg, Henry ^a,b,c  

^a UNIVERSITY OF NEVADA   (United States)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Brain tumor; Fluorescence detection; High grade glioma; Photodynamic therapy

Indexed keywords

3 TETRAHYDROXYPHENYLCHLORIN; AMINOLEVULINIC ACID; BENZOPORPHYRIN DERIVATIVE; HEMATOPORPHYRIN DERIVATIVE; PHEOPHORBIDE; PHOTOFRIN; PHOTOSENSITIZING AGENT; PROTOPORPHYRIN; TIN ETHYL ETIOPURPURIN; UNCLASSIFIED DRUG;

BLOOD BRAIN BARRIER; BRAIN TISSUE; CANCER DIAGNOSIS; CLINICAL TRIAL; DOSE RESPONSE; DOSIMETRY; DRUG UPTAKE; FLUORESCENCE; GLIOBLASTOMA; GLIOMA; HUMAN; LIGHT ABSORPTION; NEUTRON CAPTURE THERAPY; NONHUMAN; PHOTODYNAMIC THERAPY; PHOTODYNAMICS; PHOTOSENSITIVITY; PHOTOSENSITIZATION; PRIORITY JOURNAL; REVIEW; SENSITIVITY ANALYSIS; SURVIVAL; THROMBOCYTOPENIA;

EID: 33644760586     PISSN: 07318898     EISSN: None     Source Type: Journal    
DOI: 10.1615/jenvironpatholtoxicoloncol.v25.i1-2.290     Document Type: Review

References (73)

1. Perria CT, Capuzzo T, Cavagnaro G. First attempts at the photodynamic treatment of human gliomas. J Neurosurg Sci 1980; 24:119-129.
2. Origitano TC, Caron MJ, Reichman OH. Photodynamic therapy for intracranial neoplasms, a literature review and institutional experience. Mol Chem Neuropath 1994; 21:337-352.
3. Obwegeser A. Therapy of glioblastoma multiform, a cumulative experience of 10 years. Acta Neurochir (Wien) 1995; 137:29-33.
4. Muller PJ, Wilson BC. Photodynamic therapy for recurrent supratentorial gliomas. Sem Surg Oncol 1995; 11:346-354.
5. Popovic EA, Kaye AH, Hill JS. Photodynamic therapy of brain tumors. Sem Surg Oncol1995; 11:335-345.
6. Popovic EA, Kaye AH, Hill JS. Photodynamic therapy of brain tumors. J Clin Laser Med Surg 1995; 14:241-261.
7. Kostron H, Obwegeser A, Jakober R. Photodynamic therapy in neurosurgery: a review. J Photochem Photobiol B. 1996; 36:157-168.
8. Walker AE, Robins M, Weinfield FD. Epidemiology of brain tumors: The national survey of intracranial neoplasms. Neurology 1985; 35:219-226.
9. Cushing H. Intracranial tumors: Notes upon a series of two thousand verified cases with surgical mortality percentages pertaining thereto. Springfield (IL): Charles C Thomas, 1932.
10. Salcman M. Epidemiology and factors affecting survival. In: Apuzzo MLJ, Editor. Malignant cerebral glioma. Park Ridge, IL: American Association of Neurological Surgeons, 1990.
11. Holland EC. Glioblastoma multiforme: The terminator. Proc Nat Acad Sci USA 2000; 97(12):6242-44.
12. Giese A, Bjerkvig R, Berens ME, Westphal M. Cost of migration: Invasion of malignant gliomas and implications for treatment. J Clin Oncol 2003; 21(8):1624-36.
13. Wallner KE, Galicich JH, Krol G, Arbit E, Malkin MG. Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma. Int J Radiat Oncol Biol Phys 1989; 16:1405-1409.
14. Mahaley MS, Jr., Whaley RA, Blue M, Bertsch L. Central neurotoxicity following intracarotid BCNU chemotherapy for malignant gliomas. J Neuro-Oncol 1986; 3:297-314.
15. Larson DA, Gutin PH. Brachytherapy: Rationale, techniques and expectations. In: Apuzzo MLJ, Editor. Malignant cerebral glioma. Park Ridge (IL): AANS, 1990.
16. Dougherty TJ, Kaufman JE, Goldfarb A, Weishaupt KR, Boyle D, Mittleman A. Photodynamic therapy for the treatment of malignant tumors. Cancer Res 1978; 38:2628-2635.
17. Lilge L, Olivo MC, Schatz SW, MaGuire JA, Patterson MS, Wilson BC. The sensitivity of normal brain and intracranially implanted VX2 tumour to interstitial photodynamic therapy. Br J Cancer 1996; 73:332-343.
18. Lilge L, Wilson BC. Photodynamic therapy of intracranial tissues: a preclinical comparative study of four different photosensitizers. J Clin Laser Med Surg 1998; 16:81-92.
19. Stummer WS, Stocker A, Novotny A, Heimann A, Sauer O, Kempski O, Plesnila N, Wietzorrek J, Reulen HJ. In vitro and in vivo porphyrin accumulation by C6 glioma cells after exposure to 5-aminolevulinic acid. J Photochem Photobiol B 1998; 45:160-169.
20. 14C-labelled meta-tetrahydroxyphenylchlorin and 5-aminolevulinic acid in the C6 rat glioma model. Br J Cancer 1998; 78(6):733-788.
21. Madsen SJ, Sun C-H, Tromberg BJ, Wallace VP, Hirschberg H. Photodynamic therapy of human glioma spheroids using 5-aminolevulinic acid. Photochem Photobiol 2000; 72:128-134.
22. Hirschberg H, Sun C-H, Tromberg BJ, Madsen SJ. ALA and ALA-ester-mediated photodynamic therapy of human glioma spheroids. J Neurooncol 2002; 57:1-7.
23. Hill JS, Kahl SB, Kaye AH, Stylli SS, Koo M-S, Gonzales MF, Vardaxis NJ, Johnson CI. Selective tumor uptake of a boronated porphyrin in an animal model of cerebral glioma. Proc Nat Acad Sci USA 1992; 89:1785-1789.
24. Schmidt MH, Reichert KW, Ozker K, Meyer GA, Donohoe DL, Bajic DM, Whelan NT, Whelan HT. Preclinical evaluation of benzoporphyrin derivative combined with light-emitting diode array for photodynamic therapy of brain tumors. Pediatr Neurosurg 1999; 30:225-231.
25. Little FM, Gomer CJ, Hyman S, Apuzzo ML. Observations in studies of quantitative kinetics of tritium-labeled hematoporphyrin derivatives (HpDI and HpDII) in the normal and neoplastic rat brain model. J Neuro-Oncol 1984; 2:361-370.
26. Hill JS, Kaye AH, Sawyer WH, Morstyn G, Megison PD, Stylli SS. Selective uptake of hematoporphyrin derivative into human cerebral glioma. Neurosurgery 1990; 26:248-254.
27. Ji Y, Walstad DL, Brown JT, Powers SK. Relation between porphyrin distribution and blood brain barrier changes in the rat glioma model. Lasers Surg Med 1992; 12:174-179.
28. Kaye A, Morstyn G, Ashcroft RG. Uptake and retention of hematoporphyrin derivative in an in vivo/in vitro model of cerebral glioma. Neurosurgery 1985; 17:883-890.
29. Hasegawa H, Ushio Y, Hayakawa T, Yamada K, Mogami H. Changes of the bloodbrain barrier in experimental metastatic brain tumor. J Neurosurg 1983; 59:304-310.
30. Yamada K, Ushio Y, Hayakawa T, Kato A, Yamada N, Mogami H. Quantitative autoradiographic measurements of blood-brain barrier permeability in the rat glioma model. J Neurosurg 1982; 57:394-398.
31. Kloek J, Akkermans W, Beijersbergen van Henegouwen GMJ. Derivatives of 5-aminolevulinic acid for photodynamic therapy: enzymatic conversion into protoporphyrin. Photochem Photobiol 1998; 67:150-159.
32. Habgood MD, Begley DJ, Abbott NJ. Determinants of passive drug entry into the central nervous system. Cell Mol Neurobiol 2000; 20(2):231-253.
33. Muller PJ, Wilson BC. An update on the penetration depth of 630 nm light in normal and malignant human brain tissue in vivo. Phys Med Biol 1986; 31:1295-1297.
34. Muller PJ, Wilson BC. Photodynamic therapy of malignant primary brain tumors: Clinical effects, post-operative ICP, and light penetration of the brain. Photochem Photobiol 1987; 46:929-935.
35. Madsen SJ, Sun C-H, Tromberg BJ, Hirschberg H. Development of a novel indwelling balloon applicator for optimizing light delivery in photodynamic therapy. Lasers Surg Med 2001; 29:406-412.
36. Madsen SJ, Svaasand LO, Tromberg BJ, Hirschberg H. Characterization of optical and thermal distributions from an intracranial balloon applicator for photodynamic therapy. Proc SPIE 2001; 4257:41-49.
37. Engebraaten O, Hjortland GO, Hirschberg H, Fodstad O. Growth of precultured human glioma spheroids in nude rat brain. J Neurosurg 1999; 90:125-132.
38. Druckrey H. Genotypes and phenotypes of ten inbred strains of BD-rats. Arzneim Forsch 1971; 21:1274-1278.
39. Laerum OD, Rajewski MF. Neoplastic transformation of fetal brain cells in culture after exposure to ethylnitrosourea in vivo. J Natl Cancer Inst 1975; 55:1177-1187.
40. Hirschberg H, Madsen S, Angell-Petersen E, Peng Q, Sioud M, Sun C-H Sorensen D. Repetitive 5-aminolevulinic acid mediated photodynamic therapy of rat glioma. Proc SPIE 2004; 5312:405-414.
41. Chopp M, Madigan L, Dereski M, Jiang F, Li Y. Photodynamic therapy of human glioma (U87) in the nude rat. Photochem Photobiol 1996; 64(6):707-711.
42. Hebeda KM, Kamphorst W, Sterenborg HJCM, Wolbers JG. Damage to tumour and brain by interstitial photodynamic therapy in the 9L rat tumour model comparing intravenous and intratumoral administration of the photosensitizer. Acta Neurochir (Wien) 1998; 140:495-501.
43. Goetz C, Hasan A, Stummer W, Heimann A, Kempski O. Experimental research photodynamic effects in perifocal, oedematous brain tissue. Acta Neurochir (Wien) 2002; 144(2):173-179.
44. Jiang F, Lilge L, Logie B, Li Y, Chopp M. Photodynamic therapy of 9L gliosarcoma with liposome-delivered photofrin. Photochem Photobiol 1997; 65(4):701-706.
45. Jiang F, Lilge L, Grenier J, Li Y, Wilson MD, Chopp M. Photodynamic therapy of U87 human glioma in nude rat using liposome-delivered photofrin. Lasers Surg Med 1998; 22:74-80.
46. Lilge L, Portnoy M, Wilson BC. Apoptosis induced in vivo by photodynamic therapy in normal brain and intracranial tumor tissue. Br J Cancer 2000; 83:1110-1117.
47. Hebeda KM, Saarnak AE, Olivo M, Sterenborg HJ, Wolbers JG. 5-aminolevulinic acid-induced endogenous porphyrin fluorescence in 9L and C6 brain tumours and in the normal rat brain. Acta Neurochir 1998; 140:503-513.
48. Perotti C, Casas A, Fukuda H, Sacca P, Battle A. ALA and ALA hexyl ester induction of porphyrins after their systemic administration to tumour bearing mice. Br J Cancer 2002; 87:790-795.
49. Hill JS, Kahl SB, Stylli SS, Nakamura Y, Koo M-S, Kaye AH. Selective tumor kill of cerebral glioma by photodynamic therapy using a boronated porphyrin photosensitizer. Proc Nat Acad Sci USA 1995; 92:12126-12130.
50. Lobel J, MacDonald IJ, Ciesielski MJ, Barone T, Potter WR, Pollina J, Plunkett RJ, Fenstermaker RA, Dougherty TJ. 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a (HPPH) in a nude rat glioma model: implications for photodynamic therapy. Lasers Surg Med 2001; 29:397-405.
51. Stylli SS, Howes M, MacGregor L, Rajendra P, Kaye AH. Photodynamic therapy of brain tumours: evaluation of porphyrin uptake versus clinical outcome. J Clin Neurosci 2004; 11(6):584-596.
52. Rosenthal MA, Kavar B, Hill JS, Morgan DJ, Nation RL, Stylli SS, Basser RL, Uren S, Geldard H, Green MD, Kahl SB, Kaye AH. Phase I and pharmacokinetic study of photodynamic therapy for high-grade gliomas using a novel boronated porphyrin. J Clin Oncol 2001; 19(2):519-524.
53. Rosenthal MA, Kavar B, Uren S, Kaye AH. Promising survival in patients with high-grade gliomas following therapy with a novel boronated porphyrin. J Clin Neurosci 2003; 10(4):425-427.
54. Muller P, Wilson B, Lilge L, Yang V, Hetzel F, Chen Q, Fullager T, Fenstermaker R, Selker R, Abrams J. Photofrin - photodynamic therapy for malignant brain tumors. Proc SPIE 2001; 4248:34-45.
55. Muller P, Wilson B, Lilge L, Yang V, Varma A, Bogaards A, Hetzel F, Chen Q, Fullager T, Fenstermaker R, Selker R, Abrams J. Clinical studies of photodynamic therapy for malignant brain tumors: Karnovsky score and neurological score in patients with recurrent glioma treated with Photofrin-PDT. Proc SPIE 2002; 4612:40-47.
56. Schmidt MH, Meyer GA, Reichert KW, Cheng J, Krouwer HG, Ozker K, Whelan HT. Evaluation of photodynamic therapy near functional brain tissue in patients with recurrent brain tumors. J Neuro-Oncol 2004; 67:201-207.
57. Hochstetter A. High-dose laser irradiation and 5-aminolevulinic acid (5-ALA) photodynamic therapy of glioblastomas (abstract). IPA 8th World Congress of Photodynamic Medicine, Vancouver, Canada, June 7, 2001.
58. Ammirati M, Vick N, Liao YL, Ciric I, Michael M. Effect of the extent of surgical resection on survival and quality of life in patients with supratentorial glioblastomas and anaplastic astrocytomas. Neurosurgery 1987; 21:201-206.
59. Devaux BC, O'Fallon JR, Kelly PJ. Resection, biopsy and survival in malignant glial neoplasms: A retrospective study of clinical parameters, therapy, and outcome. J Neurosurg 1993; 78:767-775.
60. Zakhary R, Keles GE, Berger MS. Intraoperative imaging techniques in the treatment of brain tumors. Curr Opin Oncol 1999; 11:152-156.
61. Kelly PJ. Image-directed tumor resection. Neurosurg Clin N Am 1990; 1:81-95.
62. Aronen HJ, Cohen MS, Belliveau JW, Fordham JA, Rosen BR. Ultrafast imaging of brain tumors. Top Magn Reson Imaging 1993; 5:14-24.
63. Kraus GE, Bernstein TW, Satter M, Ezzeddine B, Hwang DR, Mantil J. A technique utilizing positron emission tomography and magnetic resonance/computed tomography image fusion to aid in surgical navigation and tumor volume determination. J Image Guid Surg 1995; 1:300-307.
64. Wagnieres GA, Star WM, Wilson BC. In vivo fluorescence spectroscopy and imaging for oncological applications. Photochem Photobiol 1998; 68:603-632.
65. Yang VXD, Muller PJ, Herman P, Wilson BC. A multispectral fluorescence imaging system: design and initial clinical tests in intra-operative Photofrin-photodynamic therapy of brain tumors. Lasers Surg Med 2003; 32:224-232.
66. Stummer W, Stepp H, Moller G, Ehrhardt A, Leonhard M, Reulen HJ. Technical principles for protoporphyrin-IX-fluorescence guided microsurgical resection of malignant glioma tissue. Acta Neurochir (Wien) 1998; 140:995-1000.
67. Stummer W, Stocker S, Wagner S, Stepp H, Fritsch C, Goetz C, Goetz AE, Kiefmann R, Reulen HJ. Intraoperative detection of malignant gliomas by 5-aminolevulinic acid-induced porphyrin fluorescence. Neurosurgery 1998; 42:518-526.
68. Stummer W, Novotny A, Stepp H, Goetz C, Bise K, Reulen HJ. Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients. J Neurosurg 2000; 93:1003-1013.
69. Stummer W, Baumgartner R. Fluorescence-guided resection of malignant gliomas utilizing 5-ALA-induced porphyrins. Photodynamics 2000; 3:6-7.
70. Bogaards A, Varma A, Collens SP, Lin A, Giles A, Yang VXD, Bilbao JM, Lilge LD, Muller PJ, Wilson BC. Increased brain tumor resection using fluorescence image guidance in a preclinical model. Lasers Surg Med 2004; 35:181-190.
71. Zimmermann A, Ritsch-Marte M, Kostron H. mTHPC-mediated photodynamic diagnosis of malignant brain tumors. Photochem Photobiol 2001; 74(4):611-616.
72. Bisland SK, Lilge L, Lin A, Rusnov R, Wilson BC. Metronomic photodynamic therapy as a new paradigm for photodynamic therapy: rationale and preclinical evaluation of technical feasibility for treating malignant brain tumors. Photochem Photobiol 2004; 80:22-30.
73. Madsen SJ, Sun C-H, Tromberg BJ, Yeh AT, Sanchez R, Hirschberg H. Effects of combined photodynamic therapy and ionizing radiation on human glioma spheroids. Photochem Photobiol 2002; 76(4):411-416.